Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Procept BioRobotics Corp (NASDAQ: PRCT) closed the day trading at $66.75 down -6.29% from the previous closing price of $71.23. In other words, the price has decreased by -$6.29 from its previous closing price. On the day, 0.77 million shares were traded. PRCT stock price reached its highest trading level at $72.605 during the session, while it also had its lowest trading level at $65.81.
Ratios:
For a better understanding of PRCT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.44 and its Current Ratio is at 8.52. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on August 11, 2023, initiated with a Overweight rating and assigned the stock a target price of $42.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 17 ’24 when Nouri Alaleh sold 10,000 shares for $62.18 per share. The transaction valued at 621,764 led to the insider holds 52,472 shares of the business.
Shiblaq Hisham sold 26,046 shares of PRCT for $1,777,499 on Jun 10 ’24. The EVP, Chief Comm. Officer now owns 55,860 shares after completing the transaction at $68.24 per share. On May 03 ’24, another insider, Nouri Alaleh, who serves as the EVP, CLO, CORP. SEC. of the company, sold 30,432 shares for $62.97 each. As a result, the insider received 1,916,428 and left with 62,472 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 3432565248 and an Enterprise Value of 3290287104. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.96 while its Price-to-Book (P/B) ratio in mrq is 12.99. Its current Enterprise Value per Revenue stands at 21.048 whereas that against EBITDA is -31.563.
Stock Price History:
The Beta on a monthly basis for PRCT is 1.02, which has changed by 0.72972274 over the last 52 weeks, in comparison to a change of 0.22226071 over the same period for the S&P500. Over the past 52 weeks, PRCT has reached a high of $77.00, while it has fallen to a 52-week low of $24.83. The 50-Day Moving Average of the stock is 2.96%, while the 200-Day Moving Average is calculated to be 38.74%.
Shares Statistics:
Over the past 3-months, PRCT traded about 623.37K shares per day on average, while over the past 10 days, PRCT traded about 565442 shares per day. A total of 50.77M shares are outstanding, with a floating share count of 48.40M. Insiders hold about 5.87% of the company’s shares, while institutions hold 82.89% stake in the company. Shares short for PRCT as of 1719532800 were 5042276 with a Short Ratio of 8.09, compared to 1717113600 on 4431420. Therefore, it implies a Short% of Shares Outstanding of 5042276 and a Short% of Float of 13.51.
